Variations in the Promoter Region of the Glutaminase Gene and the Development of Hepatic Encephalopathy in Patients With Cirrhosis
- 7 September 2010
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 153 (5) , 281-288
Abstract
Hepatic encephalopathy is a major complication of cirrhosis and is associated with a poor prognosis. To identify mutations in the gene sequence for glutaminase in humans that could be responsible for the development of hepatic encephalopathy in patients with cirrhosis. Cohort study. Outpatient clinics in 6 Spanish hospitals. 109 consecutive patients with cirrhosis in the estimation cohort, 177 patients in the validation cohort, and 107 healthy control participants. Patients were followed every 3 or 6 months until the development of hepatic encephalopathy or liver transplantation, death, or the end of the study. The genetic analyses showed that glutaminase TACC and CACC haplotypes were linked to the risk for overt hepatic encephalopathy. Mutation scanning of the glutaminase gene identified a section in the promoter region where base pairs were repeated (a microsatellite). Over a mean follow-up of 29.6 months, hepatic encephalopathy occurred in 28 patients (25.7%) in the estimation cohort. Multivariable Cox models were used to determine the following independent predictors: Child-Turcotte-Pugh stage (hazard ratio [HR], 1.6 [95% CI, 1.29 to 1.98]; P = 0.001), minimal hepatic encephalopathy (HR, 3.17 [CI, 1.42 to 7.09]; P = 0.006), and having 2 long alleles of the microsatellite (HR, 3.12 [CI, 1.39 to 7.02]; P = 0.006). The association between 2 long alleles of the microsatellite and overt hepatic encephalopathy was confirmed in a validation cohort (HR, 2.1 [CI, 1.17 to 3.79]; P = 0.012). Functional studies showed higher luciferase activity in cells transfected with the long form of the microsatellite, which suggests that the long microsatellite enhances glutaminase transcriptional activity. Other genes and allelic variants might be involved in the clinical expression of hepatic encephalopathy. This study identifies a genetic factor that is associated with development of hepatic encephalopathy in patients with cirrhosis. Instituto de Salud Carlos III, Spanish Ministry of Health.Keywords
This publication has 32 references indexed in Scilit:
- Value of the critical flicker frequency in patients with minimal hepatic encephalopathy†Hepatology, 2007
- GlutamineHepatology, 2006
- Role of Phosphate-Activated Glutaminase in the Pathogenesis of Hepatic EncephalopathyMetabolic Brain Disease, 2005
- An association study between polymorphisms in five genes in glutamate and GABA pathway and paranoid schizophreniaEuropean Psychiatry, 2005
- Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathyHepatology, 2004
- Minimal hepatic encephalopathy impairs fitness to driveHepatology, 2004
- Subclinical hepatic encephalopathy impairs daily functioningHepatology, 1998
- Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†Hepatology, 1996
- A glutaminase (Gls) gene maps to mouse chromosome 1, rat chromosome 9, and human chromosome 2*1Genomics, 1989
- The importance of the small intestine in gut ammonium production in the fasting dogGastroenterology, 1979